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Abstract. Baicalin is a flavone glycoside extracted from Scutellaria baicalensis, a
traditional Chinese herbal medicine. Numerous pharmacological effects of baicalin were
reported (e.g. antioxidant, anxiolytic); nevertheless, the most important physicochemical
properties influencing the pharmacokinetic behaviour and the concomitant oral bioavailabil-
ity have not yet been described in a comprehensive study. The aim of this project was to
characterize the acid-base, lipophilicity, biorelevant solubility and permeability properties of
the drug substance and providing scientific data to support the dosage form design. Another
important objective was the comparative evaluation of six various baicalin-cyclodextrin (CD)
inclusion complexes along with the creation of a suitable Drug Delivery System (DDS) for
this BCS IV drug. Biorelevant profiling was carried out by NMR-pH titrations, saturation
shake-flask and distribution coefficients (logP) measurements, while CD inclusion studies
were fulfilled by experimental methods (phase solubility, 1H/13C NMR, 2D ROESY) and
computational approaches. Due to low aqueous solubility (67.03 ± 1.60 μg/ml) and low
permeability (Papp = 0.037 × 10
−6 cm/s), baicalin is classified as BCS IV. The γ-CD
complexation significantly increased the solubility of baicalin (~ 5 times). The most promoted
chemical shift change occurred in baicalin-γ-CD complex. Computational studies showed
disparate binding pattern for baicalin in case of β- and γ-CD; furthermore, the calculated
complexation energy was − 162.4 kJ mol−1 for β-CD, while it was significantly stronger for γ-
CD (− 181.5 kJ mol−1). The physicochemical and structural information of baicalin and its
CD complexes introduced herein can create molecular basis for a promising DDS with
enhanced bioavailability containing a bioactive phytopharmacon.
KEY WORDS: baicalin; physicochemical analysis; computational modelling; cyclodextrins; solubility
enhancement.
INTRODUCTION
Scutellaria baicalensis Georgi (S. baicalensis G.) is one of
the most elemental herbs in traditional Chinese herbal
medicine known as Huang Qin [1]. The root is officially listed
in the Chinese Pharmacopoeia and was assumed in European
Pharmacopoeia (Ph.Eur.) 9th Edition last year [2]. The major
bioactive components in the dried root are baicalin (7-D-
glucuronic acid-5,6-dihydroxyflavone) and its aglycone,
baicalein (5,6,7-trihydroxyflavone) [3]. Baicalin has attracted
increasing scientific attention because of its various pharma-
cological activities such as antioxidant, antitumor, anti-
inflammatory and hepatoprotective effects [4, 5].
Baicalin is reported to have low water solubility
(0.054 mg/ml) and low permeability (Papp = 0.037 × 10
−6 cm/
s) [6]. The absolute bioavailability of baicalin is as low as 2.2
± 0.2% [7]. An integrated knowledge of biorelevant physical
and chemical parameters of the active substance is of
importance to select the proper formulation and delivery
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method of the drug [8]. Besides of passive transport, carrier-
mediated processes play a prominent role in the intestinal
absorption of baicalin. Different ATP-binding cassette (ABC)
transporters were identified, which are responsible for the
enterohepatic recirculation and absorption mechanisms of
baicalin [9].
Baicalin has three acidic functional moieties, one car-
boxyl and two phenolic hydroxyl groups. Proton transfer
processes can be regarded either from the aspect of dissoci-
ation or association. Because of the acidic nature of baicalin,
these processes will be characterized here in terms of acid
dissociation constants (Ka). Carboxylic acids are typically
orders of magnitude stronger than phenols. The determina-
tion of baicalin dissociation constants is hampered by its poor
water solubility and sensitivity of oxidation of the catechol
structure on its A ring [10]. The acid/base properties of
baicalin have been investigated earlier, resulting in pKa1,
pKa2 and pKa3 values of 5.05, 7.6 and 10.1, respectively [10].
However, our NMR investigations revealed that the molecule
rapidly decomposes above pH 9, making the reported values
in alkaline solutions highly dubious. We decided to undertake
the characterization of baicalin by NMR-pH titrations, where
the molecule was protected from oxidation by the antioxidant
ascorbic acid up to pH≈ 13.
A thorough physicochemical characterization necessi-
tates the determination of the octanol/water partition coeffi-
cient (log P) too, which is in close correlation with
membrane-penetration capability and is the most frequently
determined lipophilicity descriptor. While there have been
attempts in characterizing the lipophilicity of baicalin [10], we
decided to carry out a more detailed study in this area as well.
Aqueous solubility is a fundamental attribute of an active
pharmaceutical ingredient (API) and its examination is a
mandatory step during the drug discovery process [11]. New
drug molecules recently tend to have larger molecular
weights, resulting often in decreased solubility. Bloomer
et al. reveal how the solubility of the API varies as the pH
and level of surfactants varies in the gastrointestinal tract in
the fasted and fed state [12]. Furthermore, drug-food
interactions can be detected and investigated by using
biorelevant media (BRM) [13]. Simulated intestinal fluid in
fasted state (FaSSIF), in fed state (FeSSIF) and gastric fluid
in fasted state (FaSSGF) were introduced first. Simulated
fluids include different components (e.g. bile salts, lecithin,
pepsin, ions) at given ratio, which adequately predict the
in vivo behaviour of drug formulations [14].
Self-nanoemulsifying systems, nanocrystals and cyclodex-
trin complexes were developed to counterbalance the low
solubility and concomitant low oral bioavailability of baicalin
[15–17]. Cyclodextrins (CDs) are cyclic oligosaccharides
composed of α-1,4-linked D-glucopyranose units possessing
a hydrophilic exterior and hydrophobic cavity, where lipo-
philic molecules can form a non-covalently bonded inclusion
complex [18]. The cyclodextrin complexation of baicalin is
proved to be a promising method to increase its solubility;
however, only a limited number of studies were reported, in
which hydroxypropyl-β-, and β-CD were used [16, 19].
Baicalin is a class IV drug, so the enhancement of perme-
ability is also an essential part from bioavailability point of
view. Cyclodextrin derivatives can be hydrophilic or relatively
lipophilic based on their substitution and these properties can
give insight into their ability to act as permeability enhancers
[20]. Furthermore, it was described that CDs can improve
bioavailability by inhibiting P-gp (subfamily of ABC trans-
porters) induced efflux mechanisms [21]. The efflux of
baicalin is likely mediated by these kinds of ABC transporters
[9]. This fact verifies the relevance of preparation, character-
ization and analysis of different baicalin-CD complexes.
The objective of this study was to quantify the most
important biorelevant physicochemical properties of baicalin
in terms of acid/base, lipophilicity and thermodynamic
solubility in different compendial and physiological media.
To counterbalance the low solubility and permeability of this
potent phytopharmacon, the preparation and comparative
evaluation of various baicalin-CD inclusion complexes were
put into the focus. In order to reveal the molecular
interactions inside the cavity and to characterize the 3D
geometry of the complex, each species was subjected to phase
solubility, 1H NMR and 2D ROESY experiments along with
molecular modelling of the binding pattern into cyclodextrins.
Comparison of computational study and experimental results
were also in our interest.
MATERIALS AND METHODS
Materials
Baicalin (Batch: BA-161118) and its methyl ester were
purchased from Actin Chemicals, Inc. (Chengdu, China). All
CDs (α-CD, β-CD, γ-CD, (2-hydroxypropyl)-β-CD (HP-β-CD),
randommethylated β-CD (RAMEB-CD) and sulfobutylether-β-
CD (SBE-β-CD)) were kindly donated by Cyclolab R&D Ltd.
(Budapest, Hungary). Sodium taurocholate, lecithin, pepsin,
indicator molecules for the NMR-pH titrations (TRIS,
acetamidine hydrochloride and 1-methylguanidine hydrochlo-
ride) were purchased from Sigma-Aldrich (Budapest, Hungary),
the deuterated solvent D2O from VWR International (Debre-
cen, Hungary) and the DMSO-d6 from Euriso-top (Saint-Aubin,
France). Other chemicals of analytical grade were obtained from
commercial suppliers and used without further purification.
Bidistilled water was used for all NMR solutions; for solubility
analysis, freshly prepared distilled water was applied.
Preparation of Compendial and Biorelevant Media
The pH value of each solution was controlled with a
Hanna® pH 210 microprocessor pH meter (Hanna Instru-
ments, USA) and media were prepared according to litera-
ture at room temperature [22].
A total of 0.94 g of 1 M HCl and 0.35 g of NaCl were
diluted and dissolved to 1000 ml with distilled water and used
as simulated gastric fluid (SGF) with pH 1.2. This medium
served as solvent for the measurement of intrinsic solubility of
baicalin.
A total of 250 ml of 0.2 M K2HPO4 and 77 ml of 0.2 M
NaOH were homogenized and diluted to 1000 ml with
distilled water. This medium served as simulated intestinal
fluid (SIF) with pH 6.8.
Blank buffer of FaSSGF pH 1.6 (1.99 g NaCl dissolved in
900 ml distilled water, adjusted the pH to 1.6 with 1 M HCl
and filled to 1000 ml with distilled water) and phosphate
buffer pH 6.5 (0.42 g NaOH pellets + 3.95 g NaH2PO4
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monohydrate + 6.19 g NaCl dissolved in 900 ml distilled
water, adjusted the pH to 6.5 with either 1 M NaOH or 1 M
HCl and filled to 1000 ml with distilled water) were prepared
as stock solutions.
FaSSGF was produced from blank buffer of FaSSGF
pH 1.6, which was completed by 0.08 mM sodium
taurocholate, 0.02 mM lecithin, 0.1 mg/ml pepsin and has
osmolality of 120 ± 2.5 mOsmol/kg. To obtain the FaSSIF
medium, 100 ml of blank phosphate buffer (pH 6.5) was made
up by 3 mM sodium taurocholate and 0.75 mM lecithin.
FaSSIF has an osmolality of 270 ± 10 mOsmol/kg.
Determination of Thermodynamic Solubility by Saturation
Shake-Flask Method
The thermodynamic solubility of baicalin in various
media was determined by saturation shake-flask method
based on the method of Baka et al. [23]. Briefly, 10 mg of
baicalin was added to 5 ml of each solvent in sealed vials. All
samples were stirred (approx. 500 rpm) and thermostated
(IKA RT-5 power heatable magnetic stirrer, IKA Work Inc.,
USA) at 37 ± 0.5°C for 24 h allowing it to achieve thermody-
namic equilibrium. After this period, 24 h of sedimentation
cycle was adopted without stirring at 37 ± 0.5°C. To improve
the efficacy of phase-separation, the saturated supernatant of
samples was centrifuged at 14,000 rpm for 15 min (Herolab
MicroGen 16, Herolab GmbH, Wiesloch, Germany). The
aliquots (250 μl) taken for solubility experiments were
suitably diluted with blank buffers and the absorbance was
measured at λ = 316 nm by UV spectroscopy (Agilent 8453
UV-Visible Spectrophotometer, Agilent Technologies Ltd.,
USA). The drug exhibited absorption maxima (λmax) at 214,
279 and 316 nm in distilled water. Ideally, λmax selected for
the analysis of drug should not show any interference due to
solvents and excipients present in the dissolution medium. At
279 nm, baicalin showed higher molar absorptivity; however,
this wavelength was not selected for the quantification of the
drug because there was interference of excipients in
biorelevant media at this wavelength. In the solubility study,
thus, λmax 316 nm was selected for the quantification of
baicalin. In case of the distribution study, the above men-
tioned obstacle did not appear, so λmax 279 nm could be
easily used. All experiments were repeated three times and
results were calculated from the linear calibration curve of
baicalin in each media. Data are expressed as mean ± SD
(μg/ml).
NMR-pH Titrations
NMR-pH titrations were performed on a Varian
VNMRS spectrometer (600 MHz for 1H). Spectra were
recorded at 25°C. Titrations were carried out in solutions
containing 95% (v/v) H2O and 5% (v/v) D2O, with the
addition of small amounts of 0.1 M HCl and NaOH. One
molar NaOH and solid NaOH crystals were also used to
achieve highly basic pH values. The ionic strength was kept at
0.15 M by the presence of NaCl. The concentration of
baicalin and its methyl ester was 1.0 × 10−3 M and ascorbic
acid was used in large excess (5.0 × 10−3 M) to prevent the
oxidation of the studied catechol molecules in alkaline
solutions. The sample volume was 600 μl. NMR spectra
were referenced to the internal standard DSS (sodium 3-
(trimethylsilyl)-1-propanesulfonate). The water signal was
suppressed by presaturation. Spectra were processed with
VNMRj 3.2a software. pH values were read on a Metrohm
2.780.0010 precision pH meter with a 6.0258.600 Unitrode
glass Pt 1000 electrode (Metrohm AG, Herisau, Switzerland).
The pH-potentiometric system was calibrated using pH 1.68,
4.01, 6.87, 9.18 aqueous buffer solutions. In highly basic
solutions, pH was measured by NMR-pH indicator molecules
as well to avoid the uncertainty of the glass electrode pH-
meter readings in such solutions [24]. The concentration of
these pH indicators was 1.0 mM. For the analysis of NMR
titration curves of proton chemical shifts versus pH, the
software Origin Pro 8 (OriginLab Corp., Northampton,MA,
USA) was used.
Distribution Coefficient Measurements by the Stir-Flask
Method
The distribution coefficients were calculated from the
absorbance of the molecules before and after partitioning at
several octanol/water phase ratios [25]. For the pH control, a
pH 7.40 phosphate buffer and a standardized HCl solution
were used, with an ionic strength of 0.15 M in both cases. The
pH of the phosphate buffer was measured using a Metrohm
6.0204.100 combined pH glass electrode and a Metrohm 780
pH meter. The concentration change of baicalin was followed
by UV-absorbance measurements. Because of the poor water
solubility in acidic solutions, the absorbance of the octanol
phase (with an initial baicalin concentration of 4.2 × 10−5 M)
had to be monitored in the partition experiments with 0.15 M
HCl. However, at pH 7.40, the solubility in water was high
enough to follow the concentration change of baicalin in the
aqueous phase, starting from the initial concentration of 5.6 ×
10−5 M. Several water/octanol phase ratios were used,
depending on the pH and the expected log D value, to
ensure that the absorbance of baicalin after partitioning
should become approximately half as much as the original
value before partitioning. Then, the two phases were
intensively stirred for 2 h in thermostated double-walled glass
cells at constant temperature (25 ± 0.1°C). After separation of
the equilibrated phases and centrifugation, the concentration
of baicalin was determined by UV spectrophotometry
(Perkin-Elmer Lambda 15) at several values at 279 nm
(λmax). The distribution coefficients were calculated from
the absorbance of baicalin before and after partitioning.
Phase Solubility Studies
The phase solubility studies were carried out according
to the method of Higuchi and Connors [26]. Experimentally,
an excess amount of baicalin (10 mg, 2.25 mM) was added to
increasing concentrations (5, 10, 20, 40, 80 mM) of various
distilled water-based CD stock solutions at pH 4.5 (in case of
β-CD—because of its low aqueous solubility—1.25, 2.5, 5, 7.5,
10 mM stock solutions were prepared). The vials were
agitated by ultrasonication (Branson 5200, Danbury, USA)
for 4 h at constant room temperature (25°C) followed by 72 h
of equilibration phase (25°C). After sedimentation, the
saturated supernatant was taken and centrifuged at
14,000 rpm for 15 min with Herolab MicroCen 16 centrifuge
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(Herolab GmbH, Wiesloch, Germany). Samples were suit-
ably diluted with distilled water and drug concentration was
obtained via UV spectroscopy at wavelength 278 nm
(Agilent 8453 UV-Visible Spectrophotometer, Agilent Tech-
nologies Ltd., USA). All experiments were repeated three
times and results were calculated from the linear calibration
of baicalin in distilled water (R2 = 0.9992). Assuming 1:1
complex stoichiometry, the stability constants (K1:1) of
baicalin-CD inclusion complexes were calculated based on
phase solubility diagrams according to Higuchi-Connors
equation:
K1:1 ¼ slopeinterception  1−slopeð Þ ð1Þ
Signal Assignment of Baicalin and Characterization of
Baicalin-Cyclodextrin Inclusion Complexes Using 1H NMR
and 2D ROESY Experiments
Assignment and CD complexation NMR experiments
were recorded at 25°C on a Varian Mercury Plus spectrom-
eter at 400 MHz. For complete signal assignment, 15 mg of
baicalin was dissolved in 0.6 ml DMSO-d6 and transferred to
5 mm NMR tube. For the investigation of inclusion com-
plexes, cyclodextrin was dissolved in 0.7 ml D2O and baicalin
was dissolved in 0.3 ml DMSO-d6; these two stock solutions
were mixed and sonicated; after 72 h, an aliquot of 0.6 ml was
transferred into a 5-mm NMR sample tube. The resulting
solution was at 2.5 mM concentration for both compounds.
Reference baicalin solution was made by the same method
without CD. In the beginning of our experiments, minimal
precipitation was observed. Therefore, the concentration of
baicalin in the final solution was reduced from 10.0 to
2.5 mM, in which concentration was still enough for the
characterization of baicalin-cyclodextrin inclusion complexes
and gave sufficient signal/noise ratio. Chemical shifts are
given in ppm and are referenced to the residual solvent signal
(DMSO-d6: δH= 2.50 ppm; δC = 39.50 ppm). For investiga-
tion of inclusion complexes, 1H spectrum was taken from 64
scans, 24 k data points, the sweep width was 6400 Hz. For the
ROESY spinlock, a mixing time of 400 ms was used; the
number of scans was 16 and 4 k time domain points and 256
increments were applied. For complete assignment, 32 scans,
32 k data points and 6400 Hz spectral width were used for 1H
measurement and 16,384 scans, 64 k data points and
24,154 Hz sweep width were applied for 13C measurement.
In case of the gHSQC spectrum, data points were acquired
with 1 k × 512 and 4 scans were used. In the gHMBC
experiment, 1 k × 256 data points and 8 scans were applied.
gCOSY measurement was taken from 1 k × 256 data points
and 8 scans. The processing was carried out by using a cosine-
bell window function, single zero filling and automatic
baseline correction.
Molecular Modelling of the Binding into Cyclodextrin
All computations were carried out with the Gaussian09
program package (Gaussian Inc., USA, Wallingford CT,
2009) using convergence criteria of 3.0 × 10−4, 4.5 × 10−4,
1.2 × 10−3 and 1.8 × 10−3, for the gradients of the root mean
square (RMS) force, maximum force, RMS displacement and
maximum displacement vectors, respectively. The 3D struc-
tures of various cyclodextrin structures, like β-CD, γ-CD,
RAMEB-CD and SBE-β-CD as well as their complexed
forms with baicalin were optimized at B3LYP/6-31G(d) level
of theory and compared to each other [27].
RESULTS AND DISCUSSION
Determination of the Dissociation Constants of Baicalin
In baicalin, there are 12 protons connected to carbon
atoms, but in 1H NMR spectra, only the singlets of H8 and
H3 on ring A and the doublet of the aromatic H2’,6′ protons
can be easily assigned, while the other aromatic protons
occur in complex spectrum of multiplets. The protons of the
monosaccharide unit overlap with each other and with the
signals of the antioxidant ascorbic acid. The suppression of
the large water signal also interferes with the observation of
certain NMR signals. Thus, during the NMR-pH titration, we
followed the above-mentioned three chemical shift signal
sets.
Since protonation processes are instantaneous on the
NMR chemical shift time scale, the observed chemical shift
(δobsd) of a certain nucleus can be expressed as a weighted
average of chemical shifts of the non-, mono-, di- and
triprotonated forms of baicalin (B):
δobsd ¼ δB3‐xB3‐ þ δHB2‐xHB2‐ þ δH2B−xH2B− þ δH3BxH3B ð2Þ
where weighting factors are mole fractions that can be
expressed in terms of stepwise protonation macroconstants




1þK1 Hþ½  þK1K2 Hþ½ 2 þK1K2K3 Hþ½ 3
ð3Þ
Fig. 1. NMR-pH titration curves of the H2′,6′ (arom d) and H8 and
H3 protons of baicalin. Computer fits of Eq. (4) are shown in solid
lines
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Combining and rearranging Eqs. (2) and (3) yield Eq. (4)
that can be directly fitted to the 1H-NMR titration curve of
each nucleus observed.
δobsd ¼ δB3‐ þ δHB2‐K1 H
þ½  þ δH2B−K1K2 Hþ½ 2 þ δH3BK1K2K3 Hþ½ 3
1þK1 Hþ½  þK1K2 Hþ½ 2 þK1K2K3 Hþ½ 3
ð4Þ
The logarithms of the obtained protonation constants
correspond to the negative logarithms of dissociation con-
stants, namely pKa1 = logK3, pKa2 = logK2 and pKa3 = logK1
[28].
The NMR-pH titration curves can be seen in Fig. 1, while
the obtained dissociation constants are summarized in
Table I. The titration curves show that each observed nucleus
displays chemical shift changes upon dissociation of each
acidic proton.
The methyl ester of baicalin has no free carboxyl
functional group; therefore, two dissociation constants could
be fitted only. The obtained pKa values can be found in
Table I.
The first acid dissociation constant (pKa1) obviously
belongs to the carboxyl group of baicalin, because the methyl
ester derivate (without a free carboxyl group) has no
dissociation constant in the acidic region. Furthermore, two
independent studies established that the UV spectrum of
baicalin shows no profound absorption variation, just a slight
increase in absorption intensity upon the increasing solubility
of baicalin in less acidic solutions [10, 29]. The two phenolic
hydroxyl groups on C5 and C6 on ring A would cause a
marked bathochromic shift upon their deprotonation [30].
Thus, pKa2 of baicalin and the analogous pKa1 of baicalin
methyl ester belong to one kind of the phenolic hydroxyl
groups. The second phenolic hydroxyl deprotonation takes
place above pH 14, but the exact value of the pKa3 of baicalin
(or the analogous pKa2 of its methyl ester) cannot be
determined with sufficient certainty. Due to the reasons
below:
– the pH value of highly alkaline solutions can only be
determined with indicator molecules, like 1-
methylguanidine, but their chemical shift is also
influenced by the changing ionic strength and solva-
tion at these extreme pH values [31].
– the chemical shift of baicalin is also influenced by the
changing ionic strength and solvation above pH 13,
apart from the concurrent deprotonation.
– the rapid oxidation of baicalin above pH 13, even in
the presence of a large excess of ascorbic acid, makes
the observation of its signals very difficult and
uncertain.
The high pKa3 values (above pH 13) of other biologically
active catechols, like dopamine and epinephrine, can be
determined only with uncertainty for similar reasons [32].
A UV-pH titration attempted to determine the pKa2 and
pKa3 values of baicalin and claimed the 7.6 and 10.1,
respectively [10]. However, these results are highly dubious
in light of the oxidizability of baicalin in alkaline solutions.
Namely, the change in the UV-spectra of baicalin is not only
the result of protonation, but also that of the decomposition.
With the help of ascorbic acid, we could prevent this oxidative
process, and during NMR study, we could also monitor the
pH range where the molecule has remained intact. The
stability issues of baicalin were evaluated in buffered aqueous
solutions at different pH values (2.0, 3.0, 4.5, 6.8, 7.4 and 9.0)
and temperatures (4, 25 and 40°C). Acidic environment and
low temperature were protective factors to preserve the
integrity of baicalin [33].
Table I. Acid Dissociation Constants of Baicalin and Its Methyl Ester
Baicalin Baicalin methyl ester
AVG SD AVG SD
pKa1 4.21 0.02 8.78 0.05
pKa2 8.56 0.03 > 14 –
pKa3 > 14 – – –
Fig. 2. The species distribution diagram (a) and the lipophilicity profile of baicalin
(b)
Table II. Thermodynamic Solubility (μg/ml) of Baicalin in Various
Compendial and Biorelevant Media
AVG SD
Aqua dest. 67.03 1.60
pH = 1.2 (SGF) 11.64 0.44
pH = 6.8 (SIF) 10,504 330
pH = 1.6 (FaSSGF) 33.21 0.72
pH = 6.5 (FaSSIF) 8111 472
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The knowledge of pKa values allows the calculation of
species distribution diagram of baicalin (Fig. 2a), showing the
mole fraction of its variously charged forms as a function of pH.
The neutral formof baicalin (H3B) is dominant up to pH4.21.
The monoanionic form (H2B
−) reaches its maximum at the pH of
blood (pH 7.40), with 93.5%. The dianionic form (HB2−) becomes
the dominant one above pH 8.56, while the trianionic form (B3−)
starts to appear only in extremely alkaline solutions that have little
relevance to biochemical or physiological processes.
Determination of the Partition Coefficients of Baicalin
When more than one electrical species is present in
solution, the observed ratio of concentrations in partition
experiments is the distribution coefficient (D), which takes
into account the intrinsic species-specific lipophilicity of the
various electrical species present (Pi), and their mole
fractions in the aqueous phase (xi).
For baicalin, the pH-dependent distribution coefficient is
the sum of four products:
D pHð Þ ¼ ΣxiPi ¼ xB3‐PB3‐ þ xHB2‐PHB2‐ þ xH2B−PH2B− þ xH3BPH3B
ð5Þ
where xi mole fractions are the pH-dependent quantities,
while Pi parameters are the pH-independent ones. The
lipophilicity profile (the variation of log D as a function of
the aqueous pH) of a drug is essential in understanding its
pharmacokinetic behaviour [34].
The log D value of 1.28 (0.08) measured with a standard-
ized 0.15 M HCl solution characterizes the log P value of the
neutral form. In such acidic solutions, it is the dominant species
and exhibits obviously higher lipophilicity than the anionic
forms. In a previous study, the log P of baicalin was reported to
be “1.27 (pH 7)”. It is not exactly clear what the authors meant
by this, probably they calculated the log P of baicalin from a log
D measured at pH 7 [10].
However, our log D value of − 1.22 (0.02) measured with
a pH 7.40 phosphate buffer is a composite one, where
contributions of both the neutral and the monoanionic forms
are important and comparable. The relative concentration of
the dianionic form is only 6.5% here, and due to its obviously
smaller partition coefficient, it can be neglected at this
physiological pH. Thus, Eq. (6) can be simplified as
D pH 7:40ð Þ ¼ xH2B−PH2B− þ xH3BPH3B ð6Þ
The mole fraction data can be calculated similarly as
shown in Eq. (3); thus, the partition coefficient of the anionic
Fig. 3. Phase solubility profiles of baicalin and various CDs
Table III. Apparent Stability Constants (K1:1) and Types of Phase







SBE-β 102.9 AL Fig. 4. 2D ROESY NMR spectrum of Baicalin-γ-CD complex;
400 MHz; 25°C
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form can be obtained. The log P value of the anion turns out
to be − 1.28; thus, there is a 2.56 log unit difference between
the lipophilicity of the neutral and the anionic form. For
phenols, the typical difference in the octanol/water system is
around 3 log units, further verifying our results [34]. These
partition coefficients allow the construction of the lipophilicity
profile of baicalin, which can be seen in Fig. 2b. The broad black
line is the overall lipophilicity profile of themolecule, the sum of
the contributions of its two important species. The distribution
coefficient becomes monotonically smaller as the pH is
increased. The contribution of the neutral form is dominant up
to pH 6.77, but at higher pH values, the anionic form is the more
important one for the distribution coefficient.
Determination of Thermodynamic Solubility by Saturation
Shake-Flask Method
Baicalin is a weak triprotic acid (pKa1: 4.21, pKa2: 8.56, pKa3:
>14) with remarkable pH-dependent solubility. The water
solubility of baicalin was determined in distilled water (67.03 ±
1.60 μg/ml), which is in close agreement with literature data [6].
The difference could be explained by dissimilar sample prepa-
ration methods, in particular, equilibration time. In the highly
acidic environment of stomach, the neutral form of baicalin is
overwhelmingly dominant, so the measured solubility can be
considered as the intrinsic solubility of baicalin (11.64 ±
0.44 μg/ml) at pH 1.2 SGF. As the pH increases, the ionization
processes contribute significant solubility improvement (10,504
± 330 μg/ml) at pH 6.8 SIF, where baicalin exists decisively in
monoanionic form ([H2B]
−: 98.0%). Significant solubilizing
impact of FaSSGF (33.21 ± 0.72 μg/ml) was found to be
correlated to compendial pH 1.2 SGF. The ~ 3 times increase in
solubility can be explained by the presence of surface active
agents (lecithin, taurocholate) in FaSSGF. Surprisingly, FaSSIF
did not live up to our expectations. Instead of a remarkable
solubilizing effect, a minor decrease (8111 ± 472 μg/ml) of
thermodynamic solubility was found correlated to compendial
pH 6.8 SIF (Table II). Similar results were observed in the case of
weakly acidic furosemide and niflumic acid by Takács-Novák
et al. [11]. The solubility of acidic zafirlukast was also negatively
influenced by interactions of bile salt and soy lecithin, whereas
the amphiphilic molecules exhibited significant positive effect for
the weak base carvedilol [35]. The phenomena could be
explained by the fact that taurocholate and lecithin micelles
possess net negative charge; thus, an electrostatic repulsion exists
between the solute anion and the micelle. In the case of neutral
and cationic APIs, repulsive forces can be neglected.
Phase Solubility Study
Phase solubility analysis can provide valuable informa-
tion about changes in drug solubility when it interacts with
different concentrations of CDs. Since the changes of
physicochemical and biological properties of a drug are
dependent on the stability constant of CD complexes, it is
essential to determine this parameter accurately [36].
The phase solubility profile of baicalin-α-cyclodextrin
complex showed a typical BS-type solubility curve, where the
initial ascending portion is followed by a plateau region and
then a slight decrease in total baicalin solubility accompanied
by precipitation of complex. Baicalin-β-, γ-, HP-β-, RAMEB-,
SBE-β-CD complexes revealed a linear enhancement in
solubility of baicalin upon addition of increasing amounts of
CD (Fig. 3). This indicates that the complexation belongs to
the AL-type, assuming 1:1 binding stoichiometry. Solubility
enhancement of 5.47 times was demonstrated by γ-CD
Table IV. 1H NMR Chemical Shifts of Baicalin in Its Solution and Inclusion Complexes; 400 MHz; 25°C
Baicalin γ-CD +Baicalin RAMEB-CD+Baicalin SBE-β-CD+Baicalin
δ (ppm) δ (ppm) Δδ (ppm) δ (ppm) Δδ (ppm) δ (ppm) Δδ (ppm)
H-3 6.9331 6.8348 − 0.0983 6.9145 − 0.0186 6.9211 − 0.0120





− 0.0571 7.67217.7434–7.6028 − 0.0090 7.6652
7.7365–7.5939
− 0.0159
H-2′,-6′ 8.0986 8.0043 − 0.0943 8.0799 − 0.0187 8.0908 − 0.0078
Fig. 5. 1H NMR spectra of baicalin (blue), baicalin-γ-CD (red), baicalin-RAMEB-
CD (green) and baicalin-SBE-β-CD (purple); 400 MHz; 25°C
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encapsulation (67.03 μg/ml vs. 366.64 μg/ml) compared to
solubility of baicalin in DW. In case of RAMEB, SBE-β-CD
and HP-β-CD, the solubility improvement was significant, but
less expressed, 2.88, 2.55 and 1.59 times, respectively. The
inclusion complex of α- and β-CD did not reveal significant
solubility enhancement. Based on Eq. (1), the apparent
stability constants (K1:1) of host-guest complexes were
calculated (Table III).
The largest K1:1 was found in case of γ-CD (329.8 M
−1),
which can well be explained by the fact that γ-CD is neutral and
has wide internal cavity (8 glucopyranoside units). The order of
stability constants was as follows: γ-CD>RAMEB-CD> SBE-
β-CD>HP-β-CD> β-CD. The three most promising CDs were
selected and examined further (see sections “Signal Assignment
of Baicalin. Characterization of Baicalin-Cyclodextrin Inclusion
Complexes” and “Molecular Modelling of the Baicalin-
Cyclodextrin Complexations”).
Signal Assignment of Baicalin. Characterization of Baicalin-
Cyclodextrin Inclusion Complexes
The NMR analysis of baicalin was carried out in DMSO-
d6 for complete assignment and published data were com-
pleted and corrected [37, 38]. The 1H NMR chemical shifts
are in δ ppm (DMSO-d6, 400 MHz): 13.50–12.12 (1H, brs,
COOH); 12.60 (1H, brs, C-5-OH); 8.70 (1H, brs, C-6-OH);
8.07 (2H, dm, J = 7.4 Hz, H-2′,6′); 7.67–7.54 (3H, m,
H-3′,4′,5′); 7.05 (1H, s, H-8); 7.02 (1H, s, H-3); 6.05–4.65
(1H, brs, C-4”-OH); 5.53 (1H, d, J = 3.9 Hz, C-2″-OH); 5.34
(1H, d, J = 3.7 Hz, C-3″-OH); 5.25 (1H, d, J = 7.4 Hz, H-1″);
4.08 (1H, d, J = 9.5 Hz, H-5″); 3.52–3.26 (3H; m; H-2″,3″,4″).
13C NMR data in δ ppm (DMSO-d6, 100 MHz): 182.6 (C-4);
170.1 (C-6″); 163.6 (C-2); 151.3 (C-7); 149.2 (C-9); 146.8
Fig. 6. Different bonding types between baicalin and β-, γ-cyclodextrins (CD). For β-CD, the
bonding pattern consists of Bonding-A and Bonding-B, while for γ-CD, it is Bonding-A and
Bonding-C obtained by B3LYP/6-31G(d) level of theory
Table V. Energy Differences of the Complexation Process of the
Four Types of Cyclodextrins (β-CD, γ-CD, RAMEB-CD and SBE-β-





β-CD − 162.4 0.0
γ-CD − 181.5 − 19.1
RAMEB-CD − 164.2 − 1.8
SBE-β-CD − 41.0 + 121.4
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(C-5); 132.1 (C-4′); 130.9 (C-1′); 130.6 (C-6); 129.2 (C-3′,5′);
126.4 (C-2′,6′); 106.1 (C-10); 104.8 (C-3); 99.9 (C-1″); 93.7
(C-8); 75.5 (C-5″); 75.3 (C-3″); 72.8 (C-2″); 71.3 (C-4″).
To obtain direct evidences for the interaction between
baicalin and CDs, ROESY experiments were also carried out.
In the case of γ-CD, unequivocal interaction was seen for H-3
protons of the CDs and aromatic protons (H-2′,4′ and
H-3′,5′) of baicalin (Fig. 4). Weaker, but appreciable cross-
peaks were shown also for H-5 protons of γ-CD with the
aromatic protons (H-2′,4′ and H-3′,5′) and between H-3 of γ-
CD and H-3 of baicalin. Interestingly, H-8 of baicalin had
crosspeak only with H-5″. For RAMEB-CD, cross-peaks
between the same moieties were found but at lower intensity.
The baicalin-SBE-β-CD complex gave only the H-3
(baicalin)–H-3 (CD) interaction near to the noise.
Proton chemical shifts in 1D 1H NMR spectra also differ
before and after forming inclusion complexes (Table IV,
Fig. 5.). All protons of the A, B and C rings were affected by
the interaction with CDs. Most promoted chemical shift
change was found for the γ-CD complex: ca. 0.1 ppm for H-
3 and H-2′,6′; ca. 0.06 ppm for H-8 and H-3′,4′,5′. In case of
SBE-β and RAMEB-CD inclusion complexes, the chemical
shift changes were in the range of 0.01–0.02 ppm.
Most clear evidences about complexation could be
gained from the sample with γ-CD. ROESY and 1H NMR
results suggest that H-2′,6′ and H-3 are inserted into the
cavity, because these protons underwent the largest chemical
shift change in 1H spectrum, and NOE interactions could also
be developed with H-3 of CD. H-3′,4′,5′ show also NOE
correlation with H-3 of CD, but a decreased chemical shift
change could be detected, thus these protons are in the cavity,
but near the rim of the CD and became not significantly
shielded. Since aromatic protons have more intensive
through-space interaction with H-3 of CD, than H-5 protons,
it could be concluded, that the aromatic moiety is closer to
the wide rim. Concerning the complexation with RAMEB-
CD, analogous interactions could be observed as in case of
solution with γ-CD, but weaker NOE interactions and
moderate chemical shift changes could be observed. The
results for baicalin-SBE-β-CD suggest only weak interaction
between baicalin and the CD.
Molecular Modelling of the Baicalin-Cyclodextrin
Complexations
In the structures of CD, three different hydroxyl groups
can be distinguished, two at the upper ring and one at the
bottom ring for each hexose unit. According to computational
study at B3LYP/6-31G(d) level of theory, anionic baicalin
molecule docks and accommodates differently into the β-CD
and γ-CD. In the most preferred arrangement of the baicalin
in β-CD, it breaks one of the weak hydrogen bonds (HB) of
type I OH at the upper ring and forms a strong HB (Bonding-
A) with the carboxylate group of baicalin on ring-III, as
illustrated in Fig. 6. The carbonyl group on the ring-I also
forms a weak interaction with a neighbouring C–H of the
opposite hexose.
The bonding pattern is different with γ-CD. Beside the
same Bonding-A, the carbonyl group on the ring-I forms a
much stronger HB with the Type-II OH group at the opposite
site (Bonding-C). This difference can be revealed in their
bonding energy values, listed in Table V. The calculated
complexation energy in vacuum is − 162.4 kJ mol−1 for β-CD,
while it is significantly stronger for γ-CD (− 181.5 kJ mol−1),
exhibiting 19.1 kJ mol−1 beneficial energy difference in favour
of γ-CD. This bonding pattern difference can be explained in
terms of the diameter, related to the respective 7 and 8
glucose units in β- and γ-CD cyclodextrins. The strongest
interaction is forming between the carboxylate and one of the
OH groups of CD (Bonding-A), making a strong and rigid
anchor. In the case of even number (n = 8; γ-CD), the
opposite site provides beneficial OH group for the baicalin
carbonyl (Bonding-C), while for odd number (n = 7; β-CD),
the opposing wall can offer only a C–H group (Bonding-B).
To model the partially methylated cyclodextrin, we
constructed the model of RAMEB-CD according to literature
data [39]. Here, the seven hydroxyl groups (OH; type III) at
the bottom ring are completely methylated, while five out of
Fig. 7. Shapes of the two modified β-cyclodextrins (RAMEB-CD and SBE-β-CD), obtained by
B3LYP/6-31G(d) level of theory. On the right-hand side, structures represent the different bonding
patterns between baicalin and modified β-CD. RAMEB-CD and SBE-β-CD consist of Bonding-
A +Bonding-B and Bonding-B + Bonding-D, respectively
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the total of 14 the OH groups (types I and II) are methylated
at the upper ring randomly. As Fig. 7 illustrates, the original
cone shape of the β-CD has significantly changed by the
partial methylation. Namely, the narrower bottom ring of the
β-CD became extended and forms a loose ring structure. It
makes significantly larger room to accommodate of the
baicalin molecule. However, the RAMEB-CD still provides
enough hydroxyl groups at the upper ring to form strong
hydrogen bonding (Bonding-A), like the original β-CD, as
illustrated in Fig. 6. The apolar bottom part of the CD can
interact more comfortably with the phenyl substituent of the
drug molecule. The computed complexation energy is little
bit lower, than that for β-CD, which can support the
experimental findings.
The seven sulfobutylether groups in SBE-β-CD typically
replace the seven type III OH groups. Supposing a complete
deprotonation of the sulfonic acid, the seven anionic sulfo-
nate groups expand the cyclodextrin ring extremely, due to
the Coulomb repulsion of the anions. This effect opens the
bottom end of the CD and closes the upper ring. During the
complexation, the neutral form of baicalin needs to re-open
the upper ring to get into the hole and forms a similar HB
with one of the type I OH, but here the COOH points to the
CD-OH (Bonding-D). The computed energy is far less
beneficial, than that of for β-CD, which should not be
realistic, compared to the experimental result. Here, the
neglect of the whole solvent environment overestimates the
coulomb repulsion, which lowers the level of reliability. The
calculated complexation energies refer to vacuum, while in
case of phase-solubility and NMR studies, a complex solvent
system was utilized. The energy-minimised structures of CD
complexes are demonstrated in Fig. 8.
CONCLUSIONS
In this paper, the detailed physicochemical characteriza-
tion of baicalin was demonstrated, which provided valuable
information to design the proper formulation and delivery
Fig. 8. Optimized structures of various cyclodextrins and their complexed forms at B3LYP/6-
31G(d) level of theory
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route for this BCS IV active phytopharmaceutical ingredient.
Low bioavailability could be overcame by cyclodextrin
complexation; therefore, six different derivates were exam-
ined to study solubility enhancement along with stability and
geometry of inclusion complex. Molecular modelling analysis
pointed out different binding patterns and complexation
energy for each baicalin-CD complex. In accordance with
our previous hypothesis, thermodynamically the most
favourable complex proved to be baicalin-γ-CD host-guest
complex (ΔE = − 181.5 kJ mol−1), in which fact was confirmed
by phase-solubility (≈ 5.5 times solubility enhancement) and
NMR spectroscopic measurements. The demonstrated theo-
retical and experimental methods could be adopted in the
formulation development and analysis cyclodextrins contain-
ing neutral drugs. The future research direction is the
solidification and optimization of baicalin-γ-CD inclusion
complex and the phytopharmacological investigation in a
Drug Delivery System.
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